New Third Board delisting and turning to the new developments of science and technology boards!Middle sense micro IPO was questioned by the Shanghai Stock Exchange

On July 26, 2022, Wuxi Medicine Micro Electronics Co., Ltd. (hereinafter referred to as "Middle Agency") science and technology board IPO entered the "inquiry" state.

Picture source: Shanghai Stock Exchange official website

The main business of the medium -sensing micro company is the development, design and sales of SOC chips for sensing networks. The main products are Bluetooth audio sensing network SOC chips, lithium battery power management chips, and video sensing network chips. Among them, the Bluetooth audio sensing network SOC chip is applied to low -power smart audio terminals such as Bluetooth speakers, Bluetooth headsets, Bluetooth vehicles; lithium battery power management chips for functional mobile phones, smartphones, wearable smart devices and electric tools Management and protection of lithium battery power supply; video sensor network chips are used in vehicle recorders, industrial endoscopes, etc.

Financial data shows that the company's revenue in 2019, 2020, and 2021 was 239 million yuan, 203 million yuan, and 239 million yuan, respectively; the corresponding net profit corresponding to the mother-in-law at the same time was 250.909 million yuan, -26.204 million yuan, and -178.82 million Yuan.

According to the listing conditions of the "Shanghai Stock Exchange Science and Technology Innovation Board Stock Listing Rules", the company meets the "estimated market value of not less than RMB 1.5 billion in the market value of RMB 1.5 billion, and the operating income in the past year is not less than RMB 200 million, and recently Three -year R & D investment accounts for not less than 15%of the operating income in the past three years. "

1. The estimated market value is not less than RMB 1.5 billion

According to the recent valuation of the issuer's comparable company in the domestic market, the total market value of the company is expected to be less than RMB 1.5 billion after issuance.

2. In the past year, operating income has not less than RMB 200 million, and the total R & D investment in the past three years has accounted for not less than 15% of the recent three years of operating income.

According to the 2019, 2020 and 2021 Audit Report issued by the "Wuxi Medicine Microelectronics Co., Ltd." issued by the accountant of Rong Cheng (Rong Cheng's Trial [2022] 200Z0145) It is less than RMB 200 million; and the cumulative investment in R & D in the past three years has been RMB 167.072 million, accounting for 24.51%of the cumulative operating income in the past three years, not less than 15%. In summary, the medium -sized financial indicators meet the above listing standards.

This time, the development and industrialization project of wireless sensing network chip for the field of intelligent federation, industrialization projects, low -power and high -performance multi -function lithium battery power management chip upgrade projects, and the first generation of artificial intelligence supporting the Internet of Things voice entrance SOC chip research and development and industrialization projects, research and development center construction projects, supplementary funds.

In January 2016, medium -sighted micro was listed on the national stock transfer system. In June 2018, medium -sized micro -listing was terminated in the national stock transfer system.

During the listing of the national stock transfer system, the company had not disclosed the 2017 annual report and 2017 non -public offering of stocks raised funds. The administrative penalties of the Securities Regulatory Commission and its dispatch institutions and national stock transfer companies.

As of the signing of this prospectus, the issuer's controlling shareholder and actual controller Yang Xiaodong. Yang Xiaodong directly held 8 million shares of the company, accounting for 15.24%of the company's total shares. In addition, Yang Xiaodong is the actual controller of Zhuhai Zhongwei, and Zhuhai Zhongxian Weixi holds 11.375 million shares of the company, accounting for 21.67%of the company's total share capital.

In summary, Yang Xiaodong's proportion of shares directly held and through Zhuhai Zhongwei's actual control was 36.91%. Yang Xiaodong, as the company's controlling shareholder and the actual controller, did not change the actual controller status during the reporting period.

- END -